NeurosciencebioRxivPreprint
Pioglitazone improves deficits of Fmr1-KO mouse model of Fragile X syndrome by interfering with excessive diacylglycerol signaling
Andréa Geoffroy, Karima Habbas, Boglárka Zámbó…·Hervé Moine
This study shows pioglitazone reduces excessive diacylglycerol signaling in Fmr1-KO mice, improving behavioral deficits associated with Fragile X syndrome.
3 citations